These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23178950)

  • 1. Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester.
    Jäger E; Jäger A; Chytil P; Etrych T; Ríhová B; Giacomelli FC; Stěpánek P; Ulbrich K
    J Control Release; 2013 Jan; 165(2):153-61. PubMed ID: 23178950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
    Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
    J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional pH-disintegrable micellar nanoparticles of asymmetrically functionalized β-cyclodextrin-based star copolymer covalently conjugated with doxorubicin and DOTA-Gd moieties.
    Liu T; Li X; Qian Y; Hu X; Liu S
    Biomaterials; 2012 Mar; 33(8):2521-31. PubMed ID: 22204981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.
    Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic enhancement of anticancer therapeutic efficacy of HPMA copolymer doxorubicin conjugates via combination of ligand modification and stimuli-response srategies.
    Li L; Zhou M; Huang Y
    Int J Pharm; 2018 Jan; 536(1):450-458. PubMed ID: 29237570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
    Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
    Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy.
    Etrych T; Kovář L; Strohalm J; Chytil P; Ríhová B; Ulbrich K
    J Control Release; 2011 Sep; 154(3):241-8. PubMed ID: 21699933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrolytically degradable polymer micelles for drug delivery: a SAXS/SANS kinetic study.
    Filippov SK; Franklin JM; Konarev PV; Chytil P; Etrych T; Bogomolova A; Dyakonova M; Papadakis CM; Radulescu A; Ulbrich K; Stepanek P; Svergun DI
    Biomacromolecules; 2013 Nov; 14(11):4061-70. PubMed ID: 24083567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin.
    Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP
    J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel star HPMA-based polymer conjugates for passive targeting to solid tumors.
    Etrych T; Strohalm J; Chytil P; Říhová B; Ulbrich K
    J Drug Target; 2011 Dec; 19(10):874-89. PubMed ID: 21978286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reductively degradable α-amino acid-based poly(ester amide)-graft-galactose copolymers: facile synthesis, self-assembly, and hepatoma-targeting doxorubicin delivery.
    Lv J; Sun H; Zou Y; Meng F; Dias AA; Hendriks M; Feijen J; Zhong Z
    Biomater Sci; 2015 Jul; 3(7):1134-46. PubMed ID: 26221946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification.
    Chytil P; Etrych T; Konák C; Sírová M; Mrkvan T; Ríhová B; Ulbrich K
    J Control Release; 2006 Sep; 115(1):26-36. PubMed ID: 16899320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPMA-based biodegradable hydrogels containing different forms of doxorubicin. Antitumor effects and biocompatibility.
    Ríhová B; Srogl J; Jelínková M; Hovorka O; Buresová M; Subr V; Ulbrich K
    Ann N Y Acad Sci; 1997 Dec; 831():57-71. PubMed ID: 9616702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment.
    Noack AK; Lucas H; Chytil P; Etrych T; Mäder K; Mueller T
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties.
    Etrych T; Jelínková M; Ríhová B; Ulbrich K
    J Control Release; 2001 May; 73(1):89-102. PubMed ID: 11337062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination.
    Satchi-Fainaro R; Hailu H; Davies JW; Summerford C; Duncan R
    Bioconjug Chem; 2003; 14(4):797-804. PubMed ID: 12862433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles.
    Zhou Z; Li L; Yang Y; Xu X; Huang Y
    Biomaterials; 2014 Aug; 35(24):6622-35. PubMed ID: 24814427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.